News
XXII
0.0491
-33.20%
-0.0244
Gold Down Over 1%; Inovio Pharmaceuticals Shares Plummet
Benzinga · 4h ago
US Stocks Mixed; Broadcom Shares Surge On Upbeat Earnings
Benzinga · 8h ago
22nd Century Group to execute 1-for-135 reverse stock split
Seeking Alpha · 9h ago
Weekly Report: what happened at XXII last week (1202-1206)?
Weekly Report · 4d ago
Weekly Report: what happened at XXII last week (1125-1129)?
Weekly Report · 12/02 11:27
Cannabis Stock Gainers And Losers From November 29, 2024
Benzinga · 11/29 20:30
Cannabis Stock Movers For November 28, 2024
Benzinga · 11/28 20:30
Weekly Report: what happened at XXII last week (1118-1122)?
Weekly Report · 11/25 11:18
Weekly Report: what happened at XXII last week (1111-1115)?
Weekly Report · 11/18 11:15
22nd Century Group Faces Ongoing Financial Challenges
TipRanks · 11/13 04:26
22nd Century Group, Inc. Reports Financial Results for the Quarter Ended September 30, 2024
Press release · 11/12 22:13
22nd Century GAAP EPS of -$0.27, revenue of $5.95M
Seeking Alpha · 11/12 11:10
22nd Century Says Q3 Cigarette Net Revenues, Including Export Volume, Increased To $4.1M Or 18% Compared To $3.5M In The Prior Year Comparable Period
Benzinga · 11/12 11:09
22nd Century: Q3 Earnings Snapshot
Barchart · 11/12 08:47
Weekly Report: what happened at XXII last week (1104-1108)?
Weekly Report · 11/11 11:29
12 Consumer Staples Stocks Moving In Thursday's Intraday Session
Benzinga · 11/07 16:30
Weekly Report: what happened at XXII last week (1028-1101)?
Weekly Report · 11/04 11:26
Cannabis Stock Gainers And Losers From November 1, 2024
Benzinga · 11/01 20:30
Cannabis Stock Gainers And Losers From October 31, 2024
Benzinga · 10/31 20:30
Cannabis Stock Gainers And Losers From October 30, 2024
Benzinga · 10/30 20:30
More
Webull provides a variety of real-time XXII stock news. You can receive the latest news about 22Nd Century through multiple platforms. This information may help you make smarter investment decisions.
About XXII
22nd Century Group, Inc. is an agricultural biotechnology company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. Additionally, the Company provide contract manufacturing services for conventional combustible tobacco products for third-party brands. The Company operates through a single segment named Tobacco. Its tobacco segment is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. The tobacco segment is engaged in the sale of its reduced nicotine content (RNC) cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM. It uses plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products.